Does LORAZEPAM Cause Salivary hypersecretion? 165 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Salivary hypersecretion have been filed in association with LORAZEPAM (Lorazepam). This represents 0.5% of all adverse event reports for LORAZEPAM.
165
Reports of Salivary hypersecretion with LORAZEPAM
0.5%
of all LORAZEPAM reports
4
Deaths
99
Hospitalizations
How Dangerous Is Salivary hypersecretion From LORAZEPAM?
Of the 165 reports, 4 (2.4%) resulted in death, 99 (60.0%) required hospitalization, and 11 (6.7%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 165 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
SERTRALINE (163)
Which LORAZEPAM Alternatives Have Lower Salivary hypersecretion Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN